Skip to main content

Featured

Nigeria’s St. Mary’s School Attack: Over 300 Abducted in Devastating Raid

  An interior view of the Christ Apostolic Church, the day after an attack by gunmen in which people were killed and the pastor and some worshippers kidnapped, in the town of Eruku, Kwara state, Nigeria. In one of the worst mass abductions in Nigeria’s recent history, more than 300 schoolchildren and 12 teachers were kidnapped from St. Mary’s Catholic Primary and Secondary School in Papiri, Niger State, on November 21, 2025. The Christian Association of Nigeria (CAN) confirmed the updated figures after conducting a verification exercise, raising the tally from an earlier count of 215 children. The attack unfolded when armed men stormed the Catholic institution in the early hours of Friday, targeting dormitories and classrooms. Witnesses reported chaos as students attempted to flee; tragically, 88 additional students were captured while trying to escape . The abduction marks the second major school attack in Nigeria within a week, following the kidnapping of 25 girls in Kebbi S...

article

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Comments